日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A tidal disruption event from an intermediate-mass black hole revealed by comprehensive multi-wavelength observations

综合多波段观测揭示了中等质量黑洞的潮汐瓦解事件

Wang, Jialai; Huang, Mengqiu; Xue, Yongquan; Jiang, Ning; Huang, Shifeng; Wang, Yibo; Zhu, Jiazheng; Zhu, Shifu; Dai, Lixin; Jin, Chichuan; Luo, Bin; Shu, Xinwen; Sun, Mouyuan; Wang, Tinggui; Zou, Fan

PD-L1-Binding Antigen Presenters: Redirecting Vaccine-Induced Antibodies for Cancer Immunotherapy.

PD-L1结合抗原呈递细胞:将疫苗诱导的抗体重新定向用于癌症免疫治疗。

Gao Huixin, Lu Lijuan, Xiong Xiaoxiao, Li Yi, Hu Donghui, Zhang Duo, Feng Zhiwei, Liu Cong, Liu Nannan, Li Xiaoli, Tan Jizhou, Liu Ting, Peng Ling, Lu Lu, Feng Huiyi, Zhong Yan, Tan Guisen, Zhang Zhicheng, Huang Liqin, Su Chao, Xue Ying, Song Shuo, Fan Wenxia, Wang Wei, Zou Fan

Post-marketing safety profile of lumacaftor/ivacaftor in cystic fibrosis treatment: a pharmacovigilance analysis based on FAERS

囊性纤维化治疗中lumacaftor/ivacaftor上市后安全性概况:基于FAERS的药物警戒分析

Wang, Tao; Yang, Weilun; Luo, Ye; Zhan, Yue; Zou, Fan; Cui, Zhiwei; Lan, Yuanbo

The faintest, extremely variable X-ray tidal disruption event from a supermassive black hole binary?

来自超大质量黑洞双星系统的最微弱、变化极其剧烈的X射线潮汐瓦解事件?

Huang, Mengqiu; Xue, Yongquan; Li, Shuo; Liu, Fukun; Zhu, Shifu; Chen, Jin-Hong; Shen, Rong-Feng; Wang, Yibo; Yang, Yi; Jiang, Ning; Bauer, Franz Erik; Vignali, Cristian; Zou, Fan; Wang, Jialai; Filippenko, Alexei V; Luo, Bin; Qin, Chen; Quirola-Vásquez, Jonathan; Wang, Jun-Xian; Fan, Lulu; Sun, Mouyuan; Wu, Qingwen; Ni, Qingling; Brink, Thomas G; Wang, Tinggui; Zheng, Weikang; Shu, Xinwen; Zheng, Xuechen; Lin, Xiaozhi; Kong, Xu; Wang, Yijun; Luo, Yibin; Lin, Zheyu

Construction of lactylation (LA) risk signature in prostate cancer based on 4D fast DIA L-lactated quantitative genomics.

基于 4D 快速 DIA L-乳酸定量基因组学构建前列腺癌乳酸化 (LA) 风险特征

Zou Fan, Jin Yongchen, Zhang Ziteng, Zhang Yishan, Wang Mingdong, Zhu Fangge, Qiu Jinming, Ye Haoyuan, Fu Yi, Ping Hao

Real-world safety profile of elexacaftor/tezacaftor/ivacaftor: a disproportionality analysis using the U.S. FDA adverse event reporting system

elexacaftor/tezacaftor/ivacaftor 的真实世界安全性概况:基于美国 FDA 不良事件报告系统的比例失衡分析

Zhu, Chengyu; Cui, Zhiwei; Liu, Tingting; Lou, Siyu; Zhou, Linmei; Chen, Junyou; Zhao, Ruizhen; Wang, Li; Ou, Yingyong; Zou, Fan

Safety evaluation of irinotecan: a real-world disproportionality analysis using FAERS and JADER databases during the time period 2004-2024

伊立替康安全性评价:基于 FAERS 和 JADER 数据库 2004-2024 年期间的真实世界不均衡性分析

Lou, Siyu; Chen, Huayou; Cui, Zhiwei; Zhang, Xiyuan; Zhu, Chengyu; Zhou, Linmei; Ou, Yingyong; Zou, Fan

Post-marketing safety concerns with pirfenidone and nintedanib: an analysis of individual case safety reports from the FDA adverse event reporting system database and the Japanese adverse drug event report databases

吡非尼酮和尼达尼布上市后安全性问题:基于FDA不良事件报告系统数据库和日本药物不良事件报告数据库中个案安全性报告的分析

Wang, Tao; Cui, Zhiwei; Ou, Yingyong; Lou, Siyu; Chen, Huayou; Zhu, Chengyu; Zhou, Linmei; Zou, Fan

Unveiling the hidden risk of caspofungin: insights from three adverse event reporting systems and network pharmacology integration

揭示卡泊芬净的潜在风险:来自三个不良事件报告系统和网络药理学整合的见解

Li, Zhengfu; Cui, Zhiwei; Xie, De; Zou, Fan; Zhu, Chengyu

Serum uric acid to high-density lipoprotein cholesterol ratio predicts all-cause mortality in adults with metabolic dysfunction associated steatotic liver disease

血清尿酸与高密度脂蛋白胆固醇比值可预测伴有脂肪肝的代谢功能障碍成年人的全因死亡率

Ou, Yingyong; Qin, Zihan; Wang, Pinze; Zou, Fan